Conference Reports

New Orleans, Louisiana
16 March 2019 - 18 March 2019
Honolulu, Hawaii, US
06 February 2019 - 08 February 2019
Kuala Lumpur
18 January 2019 - 20 January 2019
Kuala Lumpur
22 November 2018 - 25 November 2018
Chicago, Illinois, US
10 November 2018 - 12 November 2018
San Diego, California, US
21 September 2018 - 25 September 2018
Bangkok, Thailand
28 September 2018 - 01 October 2018
Munich
25 August 2018 - 29 August 2018
Barcelona
18 March 2018 - 20 March 2018
Orlando, Florida
10 March 2018 - 12 March 2018
Los Angeles, California, US
24 January 2018 - 26 January 2018
Abu Dhabi
04 December 2017 - 08 December 2017
Anaheim, California, US
11 November 2017 - 15 November 2017
Singapore
20 October 2017 - 21 October 2017
Singapore
06 October 2017 - 08 October 2017
Barcelona
26 August 2017 - 30 August 2017
Singapore
13 July 2017 - 15 July 2017
San Diego, California, US
09 June 2017 - 13 June 2017
Houston, Texas, US
22 February 2017 - 24 February 2017
12 November 2016 - 16 November 2016
Yangon
14 October 2016 - 16 October 2016
Rome
27 August 2016 - 31 August 2016
Mexico City
04 June 2016 - 07 June 2016
New Orleans, Louisiana
10 June 2016 - 14 June 2016
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pank Jit Sin, 16 Mar 2018
Empagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, recently received the National Pharmaceutical Regulatory Agency’s approval for an update on its indication.